Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Optical Disorders Drugs 78
Oncology Drugs 76
Optical 75
Immune Disorders Drugs 68
Cardiovascular Drugs 45
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Biopharmaceuticals 37
Biotechnology 28
Genomics 28
Clinical Trials 27
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 22
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Diagnostics 8
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Therapeutic Area 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Cardiology 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

671 Results (Page 28 of 34)
- Relevance
  Sort by

Targeted Therapy Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Blood Cancer Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Proprotein Convertase Subtilisin/kexin Type 9 Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

 Report
December 2023
300 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Bi-Specific MAbS Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Solid Tumor Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Germ Cell Tumor Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Laryngeal Cancer Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Nasopharyngeal Carcinoma Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Nasal Polyposis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
77 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

Antibody Drug Conjugates Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

$Checkpoint Inhibitor Refractory Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image$

Checkpoint Inhibitor Refractory Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
January 2025
180 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

Myostatin Inhibitor - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1138EUR$1,250USD£975GBP

Ischemia Reperfusion Injury Therapeutics Market Report and Forecast 2024-2032

 Report
September 2023
200 Pages
Global

From

€3275EUR$3,599USD£2,808GBP

Cutter Stapler Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3777EUR$4,150USD£3,238GBP

Cancer Immunotherapy Market Report 2025

 Report
January 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Hypercholesterolemia Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

 Report
April 2025
186 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

Anti Asthmatic Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
101 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

Placenta growth factor inhibitors - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1365EUR$1,500USD£1,170GBP

Myasthenia Gravis - Pipeline Insight, 2024

 Clinical Trials
June 2024
80 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

671 Results (Page 28 of 34)
- 1
- 26
- 27
- 28
- 29
- 30

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.